Prasad KDV, Mangipudi MR, Vaidya RW, & Muralidhar B Organizational climate, opportunities, challenges and psychological wellbeing of the remote working employees during COVID-19 pandemic: A general linear model approach with reference to information technology industry in Hyderabad. International Journal of Advanced Research in Engineering and Technology. 2020; 11(4): 372-389.
Schaufeli WB , Bakker AA, & Salanova M. Educational and Psychological Measurement: The measurement of work engagement with a short questionnaire. A Cross-National Study. 2006; 66(4): 1-20.
Strauss ME, Smith GT Construct validity: advances in theory and methodology. Annu Rev Clin Psychol. 2009;5:1-25. doi: 10.1146/annurev.clinpsy.032408.153639. Review.
Topp CW, Østergaard SD, Søndergaard S, Bech P The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-76. doi: 10.1159/000376585. Epub 2015 Mar 28. Review.
Tuzovic S , & Kabadayi S. The influence of social distancing on employee wellbeing: A conceptual framework and research agenda. Journal of Service Management, In press. Available via: https://eprints.qut.edu.au/203329/ [Accessed January 2021]
Validation of an Employee Remote Workplace Stress Measure Embedded Within a Novel Employee Wellbeing App
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.